Literature DB >> 8395528

Molecular cloning of partial cDNAs for rat DNA topoisomerase II isoforms and their differential expression in brain development.

K Tsutsui1, K Tsutsui1, S Okada, M Watanabe, T Shohmori, S Seki, Y Inoue.   

Abstract

cDNA segments for DNA topoisomerase II were amplified from rat brain RNA after reverse transcription by the polymerase chain reaction, using degenerate oligonucleotide primers deduced from the conserved regions of topoisomerase II of higher eukaryotes. The cDNA product from a successful amplification was homogeneous in length but heterogeneous in sequence. Restriction mapping of the cloned cDNA fragments revealed that they consisted of two distinct sequence groups. DNA sequencing of representative clones from each group, designated A and B, showed that they are highly homologous to cDNAs of human topoisomerase II isoforms, alpha and beta, respectively. Northern blot analysis indicated that the transcript level for rat topoisomerase II alpha was high in embryonic brain and in the cerebellum of 2-day newborns, followed by rapid decrease to a undetectable level at 4 weeks after birth. In contrast, rat topoisomerase II beta transcript was present throughout the embryonic and postnatal stages. In the developing cerebellum, cells expressing topoisomerase II alpha were confirmed exclusively to the outer mitotic zone of the external granular layer, whereas the transcript of topoisomerase II beta was detected over the entire cortical region. These results clearly indicate that the isoform alpha is expressed only in proliferating cells. The differential expression of topoisomerase II isozymes was also observed among developed tissues. Therefore, the isozymes are most likely to be involved in the following different physiological processes: topoisomerase II alpha in cell proliferation, and topoisomerase II beta in some processes unrelated to cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395528

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Sp1 mediates cell proliferation-dependent regulation of rat DNA topoisomerase IIalpha gene promoter.

Authors:  J H Yoon; J K Kim; G B Rha; M Oh; S H Park; R H Seong; S H Hong; S D Park
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  Regulation of DNA Topoisomerase IIbeta through RNA-dependent association with heterogeneous nuclear ribonucleoprotein U (hnRNP U).

Authors:  Shinji Kawano; Mary Miyaji; Shoko Ichiyasu; Kimiko M Tsutsui; Ken Tsutsui
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

3.  Which therapy works better in choroid plexus carcinomas?

Authors:  Su G Berrak; Diane D Liu; Brigitte Wrede; Johannes E Wolff
Journal:  J Neurooncol       Date:  2010-10-26       Impact factor: 4.130

4.  In vivo etoposide-resistant C6 glioma cell line: significance of altered DNA topoisomerase II activity in multi-drug resistance.

Authors:  T Taki; T Ohnishi; N Arita; S Hiraga; T Hayakawa
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

5.  Cyclins D1 and D3 and topoisomerase II alpha in inactive pituitary adenomas.

Authors:  W Saeger; S Schreiber; D K Lüdecke
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

6.  CONDITIONAL DISTANCE CORRELATION.

Authors:  Xueqin Wang; Wenliang Pan; Wenhao Hu; Yuan Tian; Heping Zhang
Journal:  J Am Stat Assoc       Date:  2015-01-23       Impact factor: 5.033

7.  Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II.

Authors:  Lisa M Oppegard; Andrei V Ougolkov; Doris N Luchini; Renee A Schoon; John R Goodell; Harneet Kaur; Daniel D Billadeau; David M Ferguson; Hiroshi Hiasa
Journal:  Eur J Pharmacol       Date:  2008-12-03       Impact factor: 4.432

8.  The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage.

Authors:  Timothy J Wendorff; Bryan H Schmidt; Pauline Heslop; Caroline A Austin; James M Berger
Journal:  J Mol Biol       Date:  2012-07-25       Impact factor: 5.469

9.  Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype.

Authors:  Mahesh Ramamoorthy; Peter Sykora; Morten Scheibye-Knudsen; Christopher Dunn; Cindy Kasmer; Yongqing Zhang; Kevin G Becker; Deborah L Croteau; Vilhelm A Bohr
Journal:  Free Radic Biol Med       Date:  2012-08-03       Impact factor: 7.376

Review 10.  Topoisomerase II: a fitted mechanism for the chromatin landscape.

Authors:  Joaquim Roca
Journal:  Nucleic Acids Res       Date:  2008-12-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.